¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ

ÀϹݿ¬Á¦ ¹ßÇ¥ À¯ÀÇ»çÇ×

ÀϹݿ¬Á¦ ¹ßÇ¥ÀÚ´Â ¹Ýµå½Ã ¹ßÇ¥ ½½¶óÀ̵å(ÆÄ¿öÆ÷ÀÎÆ®)¸¦ »çÀü¿¡ Á¦ÃâÇÏ¼Å¾ß ¹ßÇ¥°¡ °¡´ÉÇÕ´Ï´Ù.
½½¶óÀ̵带 ±âÇÑ ³»¿¡ Á¦ÃâÇÏÁö ¾ÊÀ» °æ¿ì¿¡´Â ¹ßÇ¥ºÒ°¡´ÉÀ¸·Î °£ÁÖÇÕ´Ï´Ù.
¹ßÇ¥ ½½¶óÀ̵å¼ö´Â 15¸Å À̳»·Î 1Àå ´ç 10ÁÙ À̳»·Î Á¦ÀÛÇϽô °ÍÀ» ±ÇÀåÇϸç, ÁöÁ¤µÈ ¹ßÇ¥½Ã°£(7ºÐ ¹ßÇ¥-3ºÐ ÁúÀÇÀÀ´ä) À» Á¤È®È÷ ÁöÄÑÁֽñ⠹ٶø´Ï´Ù.

1. ÆÄÀÏ Á¦Ã⸶°¨ÀÏ : 9¿ù 17ÀÏ (¸ñ)
2. ÆÄÀÏ ÇüÅ : ÆÄ¿öÆ÷ÀÎÆ®
3. Á¦Ãâ ¹æ¹ý : ppt1@ksog.org


±¸¿¬ - Àüü   /    ¸ðüžÆÀÇÇР  /    ºÎÀÎÁ¾¾çÇР  /    »ý½Ä³»ºÐºñÇР  /    ÀϹݺÎÀΰúÇÐ

[ ±¸¿¬ - ¸ðüžÆÀÇÇÐ ]

½Ã°£ ¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
ÁÂÀå : ¹ÚÀ±±â(¿µ³²ÀÇ´ë)
13:00~13:40 OB1 ±è½Âö ºÎ»êÀÇ´ë Placenta bed¿¡¼­ÀÇ SDF¿Í visfatinÀÇ ¹ßÇöÀÌ ÀüÀÚ°£Áõ¿¡ ¹ÌÄ¡´Â È¿°ú
OB2 ¹èÁöÇý °æºÏÀÇ´ë Serum NT-proBNP level as a marker for cardiopulmonary function in preeclampsia
OB3 ÇãÇý¿ø ¿¬¼¼ÀÇ´ë C-reactive protein concentrations and differential distributions of leukocytes in Preeclampsia
OB4 ¹é¼öÁø ¿ï»êÀÇ´ë Factors predicting failure following selective pelvic arterial embolization for severe postpartum hemorrhage
ÁÂÀå : ÃÖ¿íȯ(ºÎ»êÀÇ´ë)
13:40~14:20 OB5 ±èº´Àç ¼­¿ïÀÇ´ë ÇÁ·ÎÅ׿À¹Í½º¸¦ ÀÌ¿ëÇÑ »êÀü ½ºÅ×·ÎÀ̵å Åõ¿© ÀüÈÄÀÇ ¾ç¼ö³» ´Ü¹é º¯È­ ºÐ¼®
OB6 °­Á¤¹è ÇѸ²ÀÇ´ë Self-Reported Exposure to Second-Hand Smoke and Positive Urinary Cotinine in Pregnant Nonsmokers
OB7 õ»óÈÆ ÇѾçÀÇ´ë Regression toward the mean in the fetal heart rate
OB8 ¿À°æÁØ ¼­¿ïÀÇ´ë Á¶±â¾ç¸·Æļö »ê¸ð¿¡¼­ ¾ç¼ö³» °¨¿°ÀÇ ¿øÀαտ¡ µû¸¥ ¾ç¼ö ¹× ¸ðü ¿°Áõ¹ÝÀÀÀÇ Â÷ÀÌ
ÁÂÀå : ÀüÁ¾°ü(¼­¿ïÀÇ´ë)
14:20~15:00 OB9 ¼Û½ÂÀº ¼º±Õ°üÀÇ´ë ½ÖÅÂÀӽſ¡¼­ À¶¸ð¸·¼º¿¡ µû¸¥ ÁÖ»ê±â ÀÌȯ·ü°ú »ç¸Á·ü
OB10 ±èÁ¤¸í ÀÌÈ­ÀÇ´ë ÀÚ°£ÀüÁõ°ú Àڱó» ¼ºÀåÁö¿¬À» º¸ÀÌ´Â ÀÓ»êºÎÀÇ Å¹ݿ¡¼­ÀÇ Endothelial nitric oxide synthase, Vascular endothelial growth factor, EndoglinÀÇ ¹ßÇö ºñ±³
OB11 À̹̹ü °üµ¿ÀÇ´ë Altered expression of anti-angiogenic factors (sFlt-1, sEng, and VEGF165b) in women who subsequently develop preeclampsia
OB12 ¼³ÇöÁÖ °æÈñÀÇ´ë Placental Catechol-O-methyltransferase expression in the patients with preeclampsia
ÁÂÀå : È«±â¿¬(¿ø±¤ÀÇ´ë)
15:00~15:40 OB13 À̼ø¾Ö °æ»óÀÇ´ë Antimicrobial Susceptibilities of Ureaplasma urealyticum and Mycoplasma hominis in Pregnant Women of Jinju, Korea
OB14 ±è¿¬Èñ °¡Å縯ÀÇ´ë Temporal gene expression during adipogenic differentiation of human chorion derived stem cells
OB15 Á¶±ÝÁØ °í·ÁÀÇ´ë D6 decoy receptor in missed abortion
OB16 ÀÌ°æÁø Â÷ÀÇ´ë ÁøÅë Áß Àΰ£Å¹ݿ¡¼­ À¯¹ßµÇ´Â À¯ÀüÀÚ ¹ßÇö º¯È­ÀÇ È®ÀÎÀ» À§ÇÑ mRNA oligonucleotide ¹Ì¼¼¹è¿­¹ýÀÇ ÀÌ¿ë
ÁÂÀå : ±è»çÁø(°¡Å縯ÀÇ´ë)
15:40~16:20 OB17 ÃÖ¼¼°æ °¡Å縯ÀÇ´ë Á¦´ëÇ÷ Base excess¿Í ÅÂ¾Æ »êÇ÷Áõ ¹× ½Å»ý¾Æ ¿¹ÈÄÀÇ »ó°ü°ü°è
OB18 ¼­Àº¼º ¼º±Õ°üÀÇ´ë ÀӽŠÀü ÀڱðæºÎ ¿øÃßÀýÁ¦¼úÀ» ½ÃÇà ¹ÞÀº ÀÓ»êºÎ¿¡¼­ Á¶»êÀ² ¹× ¿¹¹æÀû ÀڱðæºÎ ¿øÇü°áÂûÀÇ È¿°ú
OB19 ±èÇý¹Î À»ÁöÀÇ´ë ÀڱðæºÎ ¿ø»ÔÀýÁ¦¼úÀÌ Àӽſ¡ ¹ÌÄ¡´Â ¿µÇâ
OB20 Á¤È¿¿µ Á¶¼±ÀÇ´ë ÅÂ¾Æ ½ÉÃÊÀ½Æĸ¦ À§ÇØ »ïÂ÷ÀÇ·á±â°üÀ¸·Î Àü¿øµÇ´Â ȯÀÚµéÀÇ ÀûÀÀÁõ¿¡ ´ëÇÑ ºÐ¼®
ÁÂÀå : ¼ÕÀμ÷(°Ç±¹ÀÇ´ë)
16:20~17:00 OB21 ±è¼®¿µ °¡ÃµÀÇ´ë Assessment of a single value of hyperglycemia to predict the macrosomia in gestational diabetes mellitus(GDM)
OB22 ±èÁ¾¿î Àü³²ÀÇ´ë Àӽżº ´ç´¢¿Í Ä¡·á ÁßÀÎ Çö¼º´ç´¢ ÀӺο¡¼­ Ç×»ýÁ¦ ºÎÄ¡ ÈÄ Á¤¸ÆÇ÷Àå³» ÁöÁú°ú»êÈ­µµ¿Í ´Ü¹é»êÈ­µµÀÇ º¯È­
OB23 ¼Õ°¡Çö ¿¬¼¼ÀÇ´ë Effect of maternal insulin resistance on fetal growth in women with gestational diabetes mellitus (GDM)
OB24 ±è½ÅÇý °üµ¿ÀÇ´ë Association between First-and Second-Trimester Serum Screening Markers and Pregnancy Outcomes


[ ±¸¿¬ - ºÎÀÎÁ¾¾çÇÐ ]

½Ã°£ ¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
ÁÂÀå : ±è¿µÅÂ(¿¬¼¼ÀÇ´ë)
13:00~13:40 GO1 Á¤¿ë¿í ¿¬¼¼ÀÇ´ë Robot-assisted staging using three robotic arms for endometrial cancer: Comparison to laparoscopy and laparotomy at a single institution
GO2 ½Å¼ÒÁø °è¸íÀÇ´ë Regulatory Role of Osteopontin in Malignant Transformation of Endometrial Cancer
GO3 µ¿¼­¿¬ °æÈñÀÇ´ë Association of the hSRBC gene polymorphism with endometrial cancer
GO4 Á¤±Ù¿À °æºÏÀÇ´ë Role of FDG PET in detecting myometrial invasion in patients with clinical stage I endometrial cancer
ÁÂÀå : ¹è´ö¼ö(¼º±Õ°üÀÇ´ë)
13:40~14:20 GO5 ³²ÁÖÇö ¿ï»êÀÇ´ë The integration of aggressive surgical procedures to achieve optimal cytoreduction improves the survival of patients with FIGO stage IIIC-IV epithelial ovarian cancer
GO6 ¹éÁöÈì ¿¬¼¼ÀÇ´ë Utility of HE4 and CA125 as multiple serum tumor markers for the prediction of ovarian cancer
GO7 Á¶ÇѺ° ¿¬¼¼ÀÇ´ë Gene and protein expression profiling of newly established ovarian cancer cell lines: Identification of TOM40 and NP for ovarian cancer diagnosis and therapy
GO8 ÀÌÈñÁØ ¼­¿ïÀÇ´ë Oxaliplatin, Leucovorin and 5-fluorouracil (FOLFOX-4) in Refractory Epithelial Ovarian Cancer: A Single Institutional Experience, 2002-2009
ÁÂÀå : ±è½Âö(ÀÌÈ­ÀÇ´ë)
14:20~15:00 GO9 À̽ÅÈ­ ¿ï»êÀÇ´ë Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix; a retrospective matched case-control study
GO10 À¯½Âö ¾ÆÁÖÀÇ´ë A validation study of new risk grouping criteria for tailoring postoperative adjuvant treatment in stage IB cervical cancer patients without high-risk factors: Rethinking the use of the GOG criteria
GO11 ±èÀ±È¯ ¼­¿ïÀÇ´ë Prognostic Significance of VEGF Polymorphisms in Early Cervical Cancer
GO12 À̼öÀ± ÀÌÈ­ÀÇ´ë Genetic polymorphism of ataxia telangiectasia mutated and cervical neoplasia risk in Korean women.
ÁÂÀå : ¹ÚÁø¿Ï(´Ü±¹ÀÇ´ë)
15:00~15:40 GO13 Àü¿µÀº ¿¬¼¼ÀÇ´ë Identification of STIP-1 as a Diagnostic and Therapeutic Biomarker Candidate for Ovarian Cancer by two-dimensional DITA (differential gel electrophoresis analysis of immunoprecipitated tumor antigens)
GO14 ±è±âÇü ºÎ»êÀÇ´ë The Antitumor activity and Molecular mechanism of novel isoflavone derivative NV-128 in Epithelial ovarian cancer cells
GO15 Á¶µ¿ÈÞ ÀüºÏÀÇ´ë Awareness of human papillomavirus among public health officials
GO16 Á¶Á¤¾Æ ¼º±Õ°üÀÇ´ë Tumor-derived exosomes can induce differentiation of mesenchymal stem cells into tumor-associated myofibroblastic cells
ÁÂÀå : ÃÖÈ£¼±(Àü³²ÀÇ´ë)
15:40~16:20 GO17 ÀÌÈ«ÁÖ ÇѾçÀÇ´ë Comparison of Mathematical Models to Detect Malignant pelvic masses in the preoperative evaluation
GO18 À̼ºÇÏ °¡Å縯ÀÇ´ë A clinicopathologic study in 1,042 patients with invasive cervical cancer: 10 years experience at the Department of Obstetrics and Gynecology of Kangnam St. Mary¡¯s hospital
GO19 À±¼®±Ù °üµ¿ÀÇ´ë Evaluation of prognostic factors and clinical outcomes in uterine sarcoma
GO20 ¼ÛÀçÀ± °í·ÁÀÇ´ë Body Mass Index change during Chemotherapy and prognosis in advanced ovarian cancer
ÁÂÀå : ³ëÈïÅÂ(Ãæ³²ÀÇ´ë)
16:20~17:00 GO21 ÀÌÀ¯¹Ì Â÷ÀÇ´ë Comparison of results of treatment of patients with GTN referred to a trophoblastic disease center after failure of treatment elsewhere and primarily treated at trophoblastic disease center
GO22 ¿À¹ÎÁ¤ Àü³²ÀÇ´ë Significance of Human Papillomavirus Genotyping with High-grade Cervical Intraepithelial Neoplasia Treated by a Loop Electrosurgical Excision Procedure
GO23 ±è±âµ¿ ¿øÀڷº´¿ø Risk factors for central failure in patients with locally advanced cervical cancer
GO24 ¼ÛÀº¼· ÀÎÇÏÀÇ´ë Clinical Analysis of Patients with of LSIL


[ ±¸¿¬ - »ý½Ä³»ºÐºñÇÐ ]

½Ã°£ ¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
ÁÂÀå : °­Àμö(°üµ¿ÀÇ´ë)
13:00~13:40 RE1 ¼­¼®±³ ¿¬¼¼ÀÇ´ë The role of thioredoxin and thioredoxin binding protein-2 mRNA expression in eutopic endometrium of patients with endometriosis
RE2 ±èÇý¿¬ ¿¬¼¼ÀÇ´ë Cyclooxygenase-2 Genotype and advanced-stage endometriosis in Koreans
RE3 ÀÌ°æ¿í °í·ÁÀÇ´ë Increase of resistin levels in peritoneal fluid of endometriosis patients
RE4 Á¶½ÃÇö ¿¬¼¼ÀÇ´ë Proteomic analysis of urinary and peritoneal fluids from patients with endometriosis
ÁÂÀå : ¹ÎÀÀ±â(µ¿±¹ÀÇ´ë)
13:40~14:20 RE5 Á¶½ÃÇö ¿¬¼¼ÀÇ´ë Expression of VEGF and its receptor in peritoneal tissue and peritoneal fluids of patients with endometriosis
RE6 ÃÖÁ¾·Ä ºÎ»êÀÇ´ë Àڱ󻸷Áõ ȯÀÚÀÇ Àڱ󻸷Á¶Á÷¿¡¼­ OCT4¿Í CXCR4ÀÇ ¹ßÇö
RE7 ¹Ú»óÇý ¾ÆÁÖÀÇ´ë DETECTION OF THIOREDOXIN REDUCTASE-1 USING PROTEOMIC ANALYSIS IN ENDOMETRIUM WITH ENDOMETRIOSIS
RE8 ±èÁ¾Çö ÀüºÏÀÇ´ë Targeted disruption of nuclear factor erythroid-derived 2-like 1(NFE2L1) in osteoblasts reduces bone size and bone formation in mice
ÁÂÀå : ÃÖ¿µ¹Î(¼­¿ïÀÇ´ë)
14:20~15:00 RE9 À̵¿À± ¼º±Õ°üÀÇ´ë Effects of Hormone Therapy on Blood Homocysteine Levels in Korean Postmenopausal Women
RE10 ±èÁöÀ± ÀÌÈ­ÀÇ´ë Çѱ¹ÀÎ ´Ù³¶³­¼ÒÁõÈıºÀÇ Ç¥ÇöÇü¿¡ µû¸¥ ºÐ·ù¿¡ ´ëÇÑ ¿¬±¸
RE11 ±è³²Èñ °Ç¾çÀÇ´ë Çѱ¹ÀÎ ¹Ýº¹À¯»ê ȯÀÚÀÇ Ç÷Àü¼ºÇâÁõ ºóµµ
RE12 ±è¾Æ¸® Â÷ÀÇ´ë The relationship between endometrial and subendometrial blood flow measured by three dimensional ultrasound and the prediction of pregnancy
ÁÂÀå : ¹Ú¿øÀÏ(À»ÁöÀÇ´ë)
15:00~15:40 RE13 ÀÌ°æÀº ¿¬¼¼ÀÇ´ë Kisspeptin, Leptin and Retinol-Binding Protein-4 in Women with Polycystic Ovary Syndrome
RE14 ÁÖÁ¾±æ ºÎ»êÀÇ´ë ´Ù³¶¼º³­¼ÒÁõÈıºÀ» °¡Áø ºÒÀÓ ¿©¼º¿¡¼­ ½Å¼±ÁÖ±â¿Í µ¿°á-À¶ÇØ ¹è¾ÆÀÌ½Ä ÁÖ±âÀÇ ÀÓ½ÅÀ²°ú Âø»óÀ²
RE15 ±è³ª¿¬ ÀÌÈ­ÀÇ´ë Çѱ¹ÀÎÀÇ ´Ù³¶³­¼ÒÁõÈıº Áø´Ü ±âÁØ¿¡ ´ëÇÑ ¿¬±¸
RE16 ¾çÈ¿ÀÎ ¿¬¼¼ÀÇ´ë Metabolic and Cardiovascular Risk Factors in Women with PCOS : the Relationship with Hyperandrogenism
ÁÂÀå : ±Çµ¿Áø(°¡Å縯ÀÇ´ë)
15:40~16:20 RE17 ¼ÛÀ翬 °¡Å縯ÀÇ´ë Antioxidant effect of estrogen on bovine aortic endothelial cells
RE18 À̼º±â °Ç¾çÀÇ´ë ¸é¿ª±Û·ÎºÎ¸°¿¡ ÀÇÇÑ ÀÓÇÁ±¸ÀÇ ºÐÆ÷¿Í È°¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ
RE19 ÇÑ¸í¼® µ¿¾ÆÀÇ´ë Serum bisphenol-A concentrations from the leiomyoma patients
RE20 À±Á¤¼· °üµ¿ÀÇ´ë The Correlation Between Semen Parameters and Pregnancy Outcome after Intrauterine Insemination
ÁÂÀå : ÀÌÁ¤È£(°è¸íÀÇ´ë)
16:20~16:50 RE21 ¹ÚÇü¹« Áß¾ÓÀÇ´ë °ñ´Ù°øÁõ ¾àÁ¦ »ç¿ëÀÇ ±¹³» ÇöȲ
RE22 ±è»ó¸í Áß¾ÓÀÇ´ë °ñ´Ù°øÁõ¿¡¼­ »ýÈ­ÇÐÀû °ñÇ¥ÁöÀÚ »ç¿ëÀÇ ±¹³» ÇöȲ
RE23 ¹ÚÇöÅÂ °í·ÁÀÇ´ë Relationship between carbohydrate intake and metabolic syndrome in Korean women


[ ±¸¿¬ - ÀϹݺÎÀΰúÇÐ ]

½Ã°£ ¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
ÁÂÀå : ¹é¿ø¿µ(°æ»óÀÇ´ë)
13:00~13:40 GG1 Á¤À±¾Æ ÇѸ²ÀÇ´ë The Value of Transvaginal Sonography and Sonohysterography in the determination of the cause of abnormal uterine bleeding
GG2 ±è¹Ì°æ Â÷ÀÇ´ë Diagnosis and treatment of intrauterine adhesion in infertile women
GG3 ¹®Á¤¹Î ¼­¿ïÀÇ´ë Clinical outcomes of 1,041 cases of TLH : six years¡¯ experience in a single center
GG4 ·ùÀdz² ¼º±Õ°üÀÇ´ë ¼Ò¾Æ Ã»¼Ò³â±â ¿©¼º¿¡¼­ Àڱúμӱâ Á¾¾çÀÇ ÀÓ»ó ¾ç»ó (Ãʱ⠳»¿ø½Ã ÁÖÁõ»óÀ» Áß½ÉÀ¸·Î)
ÁÂÀå : ÀÌÀÓ¼ø(¼øõÇâÀÇ´ë)
13:40~14:20 GG5 ±èº¸¿í ¿¬¼¼ÀÇ´ë Çѱ¹ ¿©¼ºÀÇ °íÀ§Çè ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º °¨¿° ¹× Ç×ü¸é¿ªµµ Á¶»ç
GG6 ȲÁ¾ÇÏ °í·ÁÀÇ´ë HOXC10 as a Potential Marker for Discriminating Between Amnion-and Decidua-Derived Mesenchymal Stem Cells
GG7 ¹ÚÈ£ ¼º±Õ°üÀÇ´ë Cell division regulator has a strong relationship with immaturity maintenance and differentiation capability of hASCs
GG8 ¹Ú¹ÎÁ¤ ÁÁÀº¹®È­º´¿ø Alendronate°¡ °ñ¼¼Æ÷ ºÐÈ­¿Í Inhibitor of DNA binding/differentiationÀÇ ¹ßÇö¿¡ ¹ÌÄ¡´Â ¿µÇâ
ÁÂÀå : ÀÓ¿ëÅÃ(°¡Å縯ÀÇ´ë)
14:20~15:00 GG9 ÃÖ¿µÁØ °æÈñÀÇ´ë Transcatheter Ovarian Vein Embolization for the Treatment of Pelvic Congestion Syndrome in Chronic Pelvic Pain Patients
GG10 À̼öÁø ÇѾçÀÇ´ë ¾ç¼º ºÎÀΰú Áúȯ¿¡ ´ëÇÑ ·Îº¿º¸Á¶¼ö¼ú 7¿¹ÀÇ °æÇè
GG11 ¹ÚÀ¯¶õ ¿ï»êÀÇ´ë Single-port and two-port laparoscopic hysterectomy and adenxal surgery
GG12 ÀåÀºÁ¤ ¼­¿ïÀÇ´ë Office flexible hysteroscopy versus saline infusion sonography for uterine cavity assessment
ÁÂÀå : ÀÌÅÃÈÄ(°æºÏÀÇ´ë)
15:00~15:40 GG13 ±è¹Î±Ô ¼º±Õ°üÀÇ´ë Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, single-blind, comparison of vaginal sublingual and oral misoprostol
GG14 ±èºÀ¼® °üµ¿ÀÇ´ë º¹°­°æÇÏ ÀڱñÙÁ¾ ÀýÁ¦¼ú ½ÃÇà Àü GnRH agonistÀÇ Åõ¿© ȸ¼ö¿Í ÀڱñÙÁ¾ Å©±â º¯È­¿ÍÀÇ ¿¬°ü¼º¿¡ ´ëÇÑ °íÂû
GG15 ¾È±âÈÆ °í·ÁÀÇ´ë The usefulness of new catheter (Gynel) for the evaluation of female urinary tract: preliminary results
GG16 ±è½½±â Á¶¼±ÀÇ´ë Áú½Ä Àڱà ±ÙÁ¾¿ëÇؼú ¹× ¹Ì¼¼º¹°­°æÇÏ Àڱà ±ÙÁ¾¿ëÇؼú ÈÄ ÁßÁõ ÇÕº´Áõ
ÁÂÀå : À̺´ÀÍ(ÀÎÇÏÀÇ´ë)
15:40~16:20 GG17 ¹®¿©Á¤ ¿¬¼¼ÀÇ´ë Outcomes following repeat Mid Urethral Sling after failure of the initial sling procedure
GG18 ¹ÚÇöÁ¾ ¿¬¼¼ÀÇ´ë The anatomical changes of Aa and Ba points after vaginal anterior colporrhaphy and abdominal sacrocoplpexy
GG19 ±èÁÖ¸í °üµ¿ÀÇ´ë ÀڱðæºÎÅ»ÃâÀÇ Ä¡·á¿¡ °üÇÑ ÀÓ»óÀû °íÂû
GG20 ÃÖ°æ¹Ì ¼º±Õ°üÀÇ´ë Laparoscopic ureteroureteral anastomosis for distal ureteral injuries during gynecological laparoscopic surgery
ÁÂÀå : À̼º±â(°Ç¾çÀÇ´ë)
16:20~17:00 GG21 ±è¿ë¿í °¡Å縯ÀÇ´ë Single-port access total laparoscopic hysterectomy (TLH): a study of 50 cases
GG22 Á¤±Ù¿À °æºÏÀÇ´ë Single incision laparoscopic surgery with 2mm miniport: Initial gynecologic experience performed by standard trocar and instruments
GG23 ±è¹Ì¶ó °üµ¿ÀÇ´ë Hysteroscopic management of cesarean section scar pregnancy
GG24 ¹®Á¤¹Î ¼­¿ïÀÇ´ë Factors related to success and complication after transobturator tension-free vaginal tape procedure